MGLIX | RRSCX | MGLIX / RRSCX | |
Total Expense Ratio | 0.94 | 2.09 | 45% |
Annual Report Gross Expense Ratio | 0.95 | 2.17 | 44% |
Fund Existence | 16 years | 26 years | - |
Gain YTD | -0.187 | 2.311 | -8% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.28B | 372M | 613% |
Annual Yield % from dividends | 2.60 | 2.19 | 119% |
Returns for 1 year | 0.29 | 4.82 | 6% |
Returns for 3 years | -8.44 | -2.45 | 345% |
Returns for 5 years | 20.96 | 19.75 | 106% |
Returns for 10 years | 23.99 | -12.20 | -197% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSCHX | 12.77 | N/A | N/A |
Fidelity Select Chemicals | |||
FGEAX | 25.23 | N/A | N/A |
Fidelity Advisor Glbl Capital Apprec A | |||
JACJX | 18.53 | N/A | N/A |
JHancock Mid Cap Growth A | |||
JFNNX | 63.95 | -1.31 | -2.01% |
Janus Henderson Global Life Sciences N | |||
GQSCX | 12.62 | -0.37 | -2.85% |
Glenmede Disciplined US Small Cap Eq Ptf |